Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08

National Surgical Adjuvant Breast and Bowel Project protocol C-08 tested the worth of adding 1 year of bevacizumab to oxaliplatin-based standard adjuvant chemotherapy regimen in the treatment of stage II/III colon cancer. Although the overall result was negative, the possibility that a molecularly d...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pogue-Geile, Kay, Yothers, Greg, Taniyama, Yusuke, Tanaka, Noriko, Gavin, Patrick, Colangelo, Linda, Blackmon, Nicole, Lipchik, Corey, Kim, Seong Rim, Sharif, Saima, Allegra, Carmen, Petrelli, Nicholas, O’Connell, Michael J., Wolmark, Norman, Paik, Soonmyung
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2013
Témata:
Brief Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699439/
https://ncbi.nlm.nih.gov/pubmed/23821759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt140
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky